Cardiff Oncology Inc. Made Big Gain
Thu, Jun 09, 2022 at 05:30 PM
Cardiff Oncology Inc. (CRDF:NASDAQ) jumped higher at $2.25, representing a gain of 35.5%. On Wed, Jun 08, 2022, CRDF:NASDAQ touched a New 2-Week Intraday High of $1.77. The stock got featured on our News Catalysts scanner on Tue, May 17, 2022 at 10:14 AM in the 'MISCELLANEOUS' category. From Thu, May 26, 2022, the stock recorded 62.50% Up Days and 55.56% Green Days
About Cardiff Oncology Inc. (CRDF:NASDAQ)
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic...
Top 10 Gainers:
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 189.86%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 93.43%
- DBV Technologies S.A. (DBVT:NASDAQ), 79.56%
- Applied UV Inc. (AUVI:NASDAQ), 55.37%
- View Inc. (VIEW:NASDAQ), 47.98%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 35.54%
- Zynerba Pharmaceuticals, Inc. (ZYNE:NASDAQ), 35.09%
- Eros Media World PLC Ord Cl A (EMWP:NYSE), 32.81%
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 31.65%
- Digital Brands Group Inc. (DBGI:NASDAQ), 28.47%